Search
for
Sort by
Research 511–540 of 1000+
- Safety of testosterone treatment in postmenopausal women
- Current evaluation of amenorrhea
- Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism
- Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects
- Outcome of long-term treatment with the 5α-reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up
- Clinical and endocrine effects of finasteride, a 5α-reductase inhibitor, in women with idiopathic hirsutism
- Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism
- New Therapeutic Approach to the Hirsute Patient
- Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism
- Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women
- A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism
- Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism
- Finasteride in the treatment of hirsutism: new therapeutic perspectives
- Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features
- Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome
- Putative role for insulin resistance in depression risk in polycystic ovary syndrome
- The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrom patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function
- Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome
- Spironolactone in combination drug therapy for unresponsive hirsutism
- Idiopathic hypogonadotropic hypogonadism in a male runner is reversed by clomiphene citrate
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Current evaluation of amenorrhea
- Finasteride-induced secondary infertility associated with sperm DNA damage
- Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome
- Comparison of finasteride and flutamide in the treatment of idiopathic hirsutism
- Post-finasteride syndrome: a surmountable challenge for clinicians
- Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study
- Current evaluation of amenorrhea
- Hepatotoxicity with low- and ultralow-dose flutamide: a surveillance study on 203 hyperandrogenic young females
- Intermittent low-dose finasteride is as effective as daily administration for the treatment of hirsute women